Search

Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.

… Thursday, January 28, 2021 On January 28, 2021, Memorial Sloan Kettering (MSK) and more than 75 national cancer centers and organizations endorsed an open letter from the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) urging Americans to resume regular cancer screenings

Read highlights of research presented by MSK scientists at the annual ASH meeting.

… Monday, December 9, 2024 Research advances in lymphoma, leukemia, and multiple myeloma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the  American Society of Hematology (ASH) Annual Meeting , which runs December 7–10. Below are some highlights. Dual-Targeting of JAK

June’s “MSK Science Spotlight” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute.

… Monday, June 1, 2020 June’s “ MSK Science Spotlight ” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute. Dr. Vale will be presenting

Adding immunotherapy to standard treatment both before and after surgery significantly improved outcomes for people with gastric and gastroesophageal adenocarcinoma (G/GEA), according to experts from Memorial Sloan Kettering Cancer Center (MSK). Results from the MATTERHORN trial, a global phase three study, were presented today at the annual American Society of Clinical Oncology meeting and simultaneously published in the New England Journal of Medicine (NEJM).

… Sunday, June 1, 2025 Adding immunotherapy to standard treatment both before and after surgery significantly improved outcomes for people with gastric and gastroesophageal adenocarcinoma (G/GEA), according to experts from Memorial Sloan Kettering Cancer Center (MSK). Results from the MATTERHORN trial,

In an effort to stop tuberculosis (TB) from becoming progressively less treatable worldwide, the National Institutes of Health is funding a research collaboration among six institutions in close alliance. The total funding, provided by the National Institute of Allergy and Infectious Diseases, could be up to $45.7 million over seven years.

… Wednesday, February 18, 2015 In an effort to stop tuberculosis (TB) from becoming progressively less treatable worldwide, the National Institutes of Health has awarded Weill Cornell Medical College more than $6.2 million in first-year funding to support a research collaboration among six institutions

MSK researchers are studying why Black patients with breast cancer are more likely to experience heart problems that can result from treatment.

… Thursday, April 15, 2021 The moment she was diagnosed with breast cancer at age 55, Brooklyn resident Debra E. Edwards felt a combination of fear and guilt. “I made a terrible mistake by putting off my mammogram ,” she says now. “When you are busy, you don’t always do the things that are good for your

Learn why people with cancer are prone to falls and how to stay safe this winter.

… Wednesday, December 18, 2019 Summary Falls are a risk for everyone during slushy winter months, but the risk is especially high for people with cancer. MSK physical therapist Jillian Hobson walks readers through what they can do to minimize the chance of taking a tumble. Whether you find yourself walking

Learn how to talk about your lung cancer diagnosis with family, friends and others — including questions about smoking.

… Monday, November 10, 2025 When patients with lung cancer ask social worker Barbara Mitchell for guidance in talking to people about their difficult diagnosis, she lays out her bedrock principles: Your life is NOT an open book just because you have lung cancer. You do NOT need to answer every question

Memorial Sloan Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig.

… Tuesday, November 14, 2006 Memorial Sloan Kettering Cancer Center Among the Recipients Memorial Sloan Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig. Each of the six US centers will receive

A newly approved imaging technology can identify the location of prostate cancer cells, allowing doctors to choose the best treatment.

… Thursday, May 27, 2021 Prostate cancer diagnosis and treatment took a major step forward today as the US Food and Drug Administration approved an imaging technology that enables doctors to pinpoint the location of prostate cancer cells that would otherwise be hidden in the body. This new technology is